France at a glance
- Population
- 68.7 million 2025
- Life expectancy at birth
- 83.0 years, 2024
- People aged 65 and over
- 22.5 % of people, 2025
- Health spending per person
- 5,327 US$ per person, 2024
- Doctors
- 3.28 per 1,000 people, 2022
France E-Pharmacy Market Industry Trends and Forecast to 2034: Segmented by (Product, Platform, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$6.25 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $2.53 Bn | — | — |
| 2025 (base) | $2.87 Bn | +$346.3 Mn | — |
| 2026 (forecast) | $3.27 Bn | +$393.7 Mn | +13.7% |
| 2027 (forecast) | $3.72 Bn | +$447.7 Mn | +29.3% |
| 2028 (forecast) | $4.22 Bn | +$509.0 Mn | +47% |
| 2029 (forecast) | $4.80 Bn | +$578.7 Mn | +67.1% |
| 2030 (forecast) | $5.46 Bn | +$658.0 Mn | +90% |
| 2031 (forecast) | $6.21 Bn | +$748.1 Mn | +116.1% |
| 2032 (forecast) | $7.06 Bn | +$850.6 Mn | +145.7% |
| 2033 (forecast) | $8.03 Bn | +$967.2 Mn | +179.3% |
| 2034 (forecast) | $9.13 Bn | +$1.10 Bn | +217.6% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
E-pharmacies sell medicines and health products online and deliver them to the home.
Key segments of the e-Pharmacy market include product (Prescription Medicines, OTC Products and Personal Care) and platform (App-Based and Web-Based).
Rising incomes, fast-growing private hospital chains, medical tourism, government health reforms and a young, digital-first population are driving the e-Pharmacy market.
Public-private partnerships, digital health and growing middle classes in Asia, the Middle East, Africa and Latin America give the e-Pharmacy market strong room to grow.
Uneven quality standards, limited insurance coverage, high out-of-pocket costs and regulatory differences between countries hold back the e-Pharmacy market.
The e-Pharmacy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the e-Pharmacy market. Government digital health programs in France are speeding up adoption.
What doctors and scientists are doing in E-Pharmacy right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.
[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
From our blog
France
France
France
France
France
France
Pharmaceuticals · France
Pharmaceuticals · France
Medical Devices · France
Healthcare Services · France
Pharmaceuticals · France
Healthcare Services · France